These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33051476)

  • 1. Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib.
    Azuma S; Uojima H; Chuma M; Shao X; Hidaka H; Nakazawa T; Kondo M; Numata K; Iwabuchi S; Kako M; Maeda S; Koizumi W; Atsuda K
    Sci Rep; 2020 Oct; 10(1):17054. PubMed ID: 33051476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi FG; Tamburini E; Vivaldi C; Rizzato MD; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino GG; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu S; Scartozzi M
    Clin Cancer Res; 2020 Sep; 26(17):4485-4493. PubMed ID: 32371540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.
    Yamauchi M; Ono A; Ishikawa A; Kodama K; Uchikawa S; Hatooka H; Zhang P; Teraoka Y; Morio K; Fujino H; Nakahara T; Murakami E; Miki D; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Hayes CN; Fujita M; Nakagawa H; Yasui W; Aikata H; Chayama K
    Clin Transl Gastroenterol; 2020 May; 11(5):e00179. PubMed ID: 32677805
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Marisi G; Petracci E; Raimondi F; Faloppi L; Foschi FG; Lauletta G; Iavarone M; Canale M; Valgiusti M; Neri LM; Ulivi P; Orsi G; Rovesti G; Vukotic R; Conti F; Cucchetti A; Ercolani G; Andrikou K; Cascinu S; Scartozzi M; Casadei-Gardini A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOS3 Gene rs1799983 and rs2070744 Polymorphisms in Patients with Unstable Angina.
    Pawlik A; Błaszczyk H; Rać M; Maciejewska-Skrendo A; Safranow K; Dziedziejko V
    J Vasc Res; 2020; 57(3):136-142. PubMed ID: 32224624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
    Shigesawa T; Maehara O; Suda G; Natsuizaka M; Kimura M; Shimazaki T; Yamamoto K; Yamada R; Kitagataya T; Nakamura A; Suzuki K; Ohara M; Kawagishi N; Umemura M; Nakai M; Sho T; Morikawa K; Ogawa K; Ohnishi S; Sugiyama M; Mizokami M; Takeda H; Sakamoto N
    Carcinogenesis; 2021 Feb; 42(1):58-69. PubMed ID: 32449510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
    Casadei Gardini A; Marisi G; Faloppi L; Scarpi E; Foschi FG; Iavarone M; Lauletta G; Corbelli J; Valgiusti M; Facchetti F; Della Corte C; Neri LM; Tamberi S; Cascinu S; Scartozzi M; Amadori D; Nanni O; Tenti E; Ulivi P; Frassineti GL
    Oncotarget; 2016 May; 7(19):27988-99. PubMed ID: 27058899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine.
    García-Martín E; Navarro-Muñoz S; Rodriguez C; Serrador M; Alonso-Navarro H; Calleja M; Turpín-Fenoll L; Recio-Bermejo M; García-Ruiz R; Millán-Pascual J; Navacerrada F; Plaza-Nieto JF; García-Albea E; Agúndez JAG; Jiménez-Jiménez FJ
    Pharmacogenomics J; 2020 Jun; 20(3):426-432. PubMed ID: 31792366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
    Yang Y; Zhou Y; Lu M; An Y; Li R; Chen Y; Lu DR; Jin L; Zhou WP; Qian J; Wang HY
    Mol Carcinog; 2012 Jul; 51(7):515-21. PubMed ID: 21656577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study.
    Gamil S; Erdmann J; Abdalrahman IB; Mohamed AO
    BMC Med Genet; 2017 Nov; 18(1):128. PubMed ID: 29132319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
    Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
    Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis.
    Agúndez JAG; García-Martín E; Rodríguez C; Benito-León J; Millán-Pascual J; Díaz-Sánchez M; Calleja P; Turpín-Fenoll L; Alonso-Navarro H; García-Albea E; Plaza-Nieto JF; Jiménez-Jiménez FJ
    J Neural Transm (Vienna); 2020 Aug; 127(8):1167-1175. PubMed ID: 32449012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREDICTING THE OCCURRENCE OF PRIMARY OPEN-ANGLE GLAUCOMA DEPENDING ON THE GENETIC POLYMORPHISM ENDOTHELIAL NO SYNTHASE (NOS3) GENE.
    Isaiev O; Serdiuk V; Ziablitsev D
    Wiad Lek; 2022; 75(12):3087-3093. PubMed ID: 36723332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian Rhythms of Endothelial Nitric Oxide Synthase and Toll-like Receptors 2 Production in Females with Rheumatoid Arthritis Depending on NOS3 Gene Polymorphism.
    Zaichko K; Zaichko N; Maievskyi O; Korotkyi O; Falalyeyeva T; Fagoonee S; Pellicano R; Abenavoli L; Stanislavchuk M
    Rev Recent Clin Trials; 2020; 15(2):145-151. PubMed ID: 32297585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between NOS3 Gene Polymorphisms and Hypoxic-Ischemic Encephalopathy Susceptibility and Symptoms in Chinese Han Population.
    Wu Y; Zhu Z; Fang X; Yin L; Liu Y; Xu S; Li A
    Biomed Res Int; 2016; 2016():1957374. PubMed ID: 28070505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
    PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
    Yamaoka K; Kodama K; Kawaoka T; Kosaka M; Johira Y; Shirane Y; Miura R; Yano S; Murakami S; Amioka K; Naruto K; Ando Y; Kosaka Y; Uchikawa S; Uchida T; Fujino H; Nakahara T; Murakami E; Okamoto W; Yamauchi M; Miki D; Imamura M; Takahashi S; Nagao A; Chayama K; Aikata H
    PLoS One; 2022; 17(1):e0262675. PubMed ID: 35041693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol.
    Gardini AC; Faloppi L; Aprile G; Brunetti O; Caparello C; Corbelli J; Chessa L; Bruno D; Ercolani G; Leonetti A; Stefano G; Farella N; Foschi FG; Lanzi A; Dadduzio V; Marisi G; Masi G; Negri FV; Pagan F; Santini D; Scarpi E; Silletta M; Silvestris N; Tamburini E; Tassinari D; Vivaldi C; Gentilucci UV; Zagonel V; Calvetti L; Cascinu S; Frassineti GL; Scartozzi M
    Tumori; 2018 Dec; 104(6):476-479. PubMed ID: 29739298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature.
    Shibata O; Kamimura K; Ko M; Sakai N; Abe H; Morita S; Mizusawa T; Sato H; Sakamaki A; Terai S
    Intern Med; 2021 Jun; 60(11):1709-1715. PubMed ID: 33390501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nos3 Gene Rs1799983 and Rs2070744 Polymorphisms in Patients with Periodontal Disease.
    Mazurek-Mochol M; Kozak M; Sawczuk M; Maciejewska A; Malinowski D; Safranow K; Pawlik A
    Folia Biol (Praha); 2018; 64(2):59-64. PubMed ID: 30338757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.